Telix Receives FDA Approval Following Oil Price Rise to Above $107

Telix obtained a critical US Food and Drug Administration approval, advancing its telehealth service for patients over age 65. The regulatory win followed the Australian Securities Exchange recovering slightly after a significant weekly drop. Meanwhile, global oil prices reacted to geopolitical risks in the Middle East. Brent crude surged above US$107 as attacks on Gulf shipping routes increased. US inflation data aligned with expectations, yet market participants anticipate the Federal Reserve will initiate a rate hike during its upcoming meeting. Wall Street gained ground following Friday's losses. On the Australian side, mining sectors lagged as Woodside Energy saw minimal movement after a board change at Northern Star Resources.